03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Paroxat 40mg* : | |
Type | Medicine Non Marketed |
Originator | G |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Hexal |
Responsible Party | Hexal AG |
Origin | Germany |
Manufacturer | Salutas Pharma GmbH |
Manufacturing Type | G |
Origin | Germany |
ATC | N06AB05 |
Paroxat 40mg* :
Paroxat 40mg* :
Paroxat 40mg* :
Paroxat 40mg* :
Paroxat 40mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abnormal dreams | Common |
Acute glaucoma | Very rare |
Agitation | Common |
Akathisia | Rare |
Allergic reaction | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Asthenia | Common |
Bleeding | Uncommon |
Blood cholesterol increased | Common |
Confusion | Uncommon |
Constipation | Common |
Convulsion | Rare |
Decreased appetite | Common |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Dry mouth (Xerostomia) | Common |
Ecchymosis | Uncommon |
Erythema multiforme | Very rare |
Extrapyramidal disorder | Uncommon |
Galactorrhoea | Rare |
Gastrointestinal bleeding | Very rare |
Hallucination | Uncommon |
Headache | Common |
Hepatic enzyme increased | Rare |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
Hepatitis | Very rare |
Hyperprolactinaemia (Hyperprolactinemia) | Rare |
Hyponatraemia (Hyponatremia) | Rare |
Inappropriate antidiuretic hormone secretion (SIADH) | Very rare |
Insomnia | Common |
Jaundice | Very rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Manic reactions | Rare |
Mydriasis (dilated pupils) (Dilatation pupillary) | Uncommon |
Nausea | Very Common |
Nightmares | Common |
Oedema peripheral | Very rare |
Orthostatic hypotension | Uncommon |
Photosensitivity | Very rare |
Restless legs syndrome | Rare |
Serotonin syndrome | Very rare |
Sexual dysfunction | Very Common |
Sinus tachycardia | Uncommon |
Skin rash | Uncommon |
Somnolence | Common |
Stevens-Johnson syndrome | Very rare |
Sweating | Common |
Thrombocytopenia (Thrombopenia) | Very rare |
Tremor | Common |
Urinary incontinence | Uncommon |
Urinary retention | Uncommon |
Urticaria | Very rare |
Vision blurred | Common |
Vomiting | Common |
Weight increased (weight gain) | Common |
Yawning | Common |
Paroxat 40mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Paroxat 40mg* MoH 6062 :
Form | Tablet, Film-Coated |
Package Size | Box of 20 |
Strength | 40mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 24999/07 |
Submission date | 01/01/2007 |
Registration Year | 2010 |
Archived Date | 2018 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 20 | |
● Public Price: | 42 QAR | ( 1,031,436.00 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 2,1 QAR | ( 49,116.00 LBP ) |
● Pharmacy Price: | 33.907511713049 QAR | ( 832700.67264906 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 20 | |
● Public Price: | 6.72 OMR | ( 1,550,532.48 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,336 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 20 | |
● Public Price: | 6.48 JOD | ( 811,432.08 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,324 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 4.94 JOD | ( 618591.74 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 20 | |
● Public Price: | 5.23 KWD | ( 1,535,428.63 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,2615 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 4.42 KWD | ( 1297628.02 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File